ARTICLE | Politics & Policy
Regulatory reprieve with Brexit delay
April 11, 2019 8:23 PM UTC
An EU-granted extension for Brexit means short-term clarity for biopharma companies expecting EMA or European Commission decisions before the new Oct. 31 deadline.
The U.K. had been scheduled to leave the union Friday...
BCIQ Company Profiles
European Federation of Pharmaceutical Industries and Associations